Search company, investor...

Composite Applications Group

Founded Year


About Composite Applications Group

Composite Applications Group connects, collaborates, and commercializes technologies and products in the composites and composite-related industries. It connects the original equipment managers (OEMs) with the composites supply chain to commercialize ideas with the OEM technology partners. Composite Applications Group was founded in 2013 and is based in Mcdonald, Tennessee.

Headquarters Location

10607 Lee Highway

McDonald, Tennessee, 37353,

United States

Missing: Composite Applications Group's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Composite Applications Group's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Composite Applications Group Frequently Asked Questions (FAQ)

  • When was Composite Applications Group founded?

    Composite Applications Group was founded in 2013.

  • Where is Composite Applications Group's headquarters?

    Composite Applications Group's headquarters is located at 10607 Lee Highway, McDonald.

  • Who are Composite Applications Group's competitors?

    Competitors of Composite Applications Group include Atomic-6 and 4 more.

Compare Composite Applications Group to Competitors

Talima Therapeutics

Talima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. With a unique approach to therapy, we design customized drug-delivery systems that optimize the local therapeutic performance and reduce the undesired systemic side effects enabling us to address unmet needs or underserved markets. We foster a collaborative environment and strive for excellence internally and with our partners. Our lead product is currently in Phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the nails and we are in the process of planning its pivotal trials.


utilized "combinatorial chemistry" technology to discover lead therapeutic and diagnostic compounds.�MACUGEN, approved for wet age-related macular degeneration, was discovered using this technology. Upon NeXagen's merger with Vestar, Inc., the company also marketed and developed liposomal drug delivery products.

Westfield Life Sciences Fund

Launched in July of 2000, the Westfield Life Sciences Fund invests in healthcare companies across the capitalization spectrum including medical devices, drugs, drug delivery, biotechnology, and healthcare services. Portfolio manager Will Muggia employs a fundamental, bottom up research driven process that focuses on preservation of capital and long-term outperformance. Westfield's industry network developed by Mr. Muggia and his analytical team is critical to new idea generation.

Felton International

Pulse NeedleFree Systems is a medical technology company focused on development of needle-free pharmaceutical injection systems for the animal health and human health industries. Pulse's animal health injection systems are marketed to large livestock producers in the United States and select international markets.

Mirus Bio Logo
Mirus Bio

Mirus Bio is a life science company focused on discovering, developing, and commercializing nucleic acid-based technologies and products. Mirus Bio operates in the fields of RNA interference and gene therapy, specializing in nucleic acid chemistry and delivery. On May 18, 2021, Gamma Biosciences acquired a majority stake in Mirus Bio. The terms of the transaction were not disclosed.

EZRA Innovations

EZRA Innovations currently holds exclusive worldwide rights in a controlled-release drug delivery system. Drug Surfactant Complex (DSC) Deoxycholate is used in combination with active pharmaceutical ingredients (API), DSC possesses the ability to change the chemical moiety of existing drugs and better extend release rates.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.